RFA
CKPT

Reilly Financial Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Reilly Financial Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$3K Hold
100
– – ﹤0.01% 919
2021
Q3 		$3K Hold
100
– – ﹤0.01% 806
2021
Q2 		$3K Buy
100
+50
+100% +$1.39K ﹤0.01% 851
2021
Q1 		$2K Hold
50
– – ﹤0.01% 905
2020
Q4 		$1K Hold
50
– – ﹤0.01% 843
2020
Q3 		$1K Buy
+50
New +$1.2K ﹤0.01% 787

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Reilly Financial Advisors's CKPT Position: Q4 2021 in Review

Reilly Financial Advisors held its Checkpoint Therapeutics (CKPT) position steady in Q4 2021 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Reilly Financial Advisors first reported a position in CKPT in Q3 2020 and has held it in 6 quarters since. 62 funds tracked by Wall St. Rank hold CKPT as of Q4 2021.

  • Reilly Financial Advisors held 100 shares of Checkpoint Therapeutics worth $3K as of Q4 2021.
  • Reilly Financial Advisors left its Checkpoint Therapeutics share count unchanged in Q4 2021.
  • Checkpoint Therapeutics made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #919 holding.
  • Reilly Financial Advisors first reported a position in Checkpoint Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • 62 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.